Abstract Supplementary Information: The online version contains supplementary material available at 10.1038/s41598-025-27618-1. Article type: Research Article Keywords: Endocannabinoids, Cannabinoids, CBD,…
Abstract Aims: Cannabidiol (CBD), the main non‐intoxicating compound from the cannabis plant, is regularly used by patients with chronic pain…
Abstract Background: Cannabis is commonly used as a self-prescribed treatment for anxiety and depression, but few studies have evaluated these…
Abstract Background: Prenatal exposure to cannabis (or more specifically, delta 9‐tetrahydrocannabinol [Δ9‐THC]) has been consistently linked to low birthweight. Animal…
Abstract Background: Tetrahydrocannabivarin (THCV) is a phytocannabinoid commonly found in cannabis with potential pharmacological properties; however, its post-acute pharmacokinetics (PK)…
Abstract The public is increasingly reporting using cannabis for anxiety relief. Both cannabis use and the endocannabinoid system have been…
Abstract Background: Prenatal exposure to cannabis may influence childhood cognition and behavior, but the epidemiologic evidence is mixed. Even less…
Abstract Background: The transient receptor potential vanilloid 1 (TRPV1) participates in thermosensation and inflammatory pain, but its immunomodulatory mechanisms remain…
Abstract Purpose: Cannabichromene (CBC) is a phytocannabinoid commonly found in cannabis, yet its acute post-dose pharmacokinetics (PK) have not been…
Abstract This cohort study examines the association between medical cannabis product use and exposure to Δ9-tetrahydrocannabinol and cannabidiol by quantifying…